tm
Seeing Is Believing
tm
Seeing Is Believing
LPCN is currently covered by 1 analysts
Lipocine's activity chart (see below) currently has 7 price targets and 10 ratings on display. The stock rating distribution of LPCN is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 74.29% with an average time for these price targets to be met of 344.4 days.
Highest price target for LPCN is $10, Lowest price target is $2.
Most recent stock forecast was given by from HC WAINWRIGHT on 06-Apr-2026. First documented stock forecast 20-Dec-2016.
Currently out of the existing stock ratings of LPCN, 3 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 29-May-2025
$15
5 months 2 days ago
(06-Apr-2026)
6/7 (85.71%)
$5.31 (54.80%)
160
10.5
Buy Since 03-Feb-2022
$3
$0.8 (36.36%)
$3
4 years 5 months 30 days ago
(09-Mar-2022)
3/3 (100%)
$-22.5 (-88.24%)
664
Buy Since 18-Jan-2019
$59.5
$52.35 (732.17%)
5 years 13 days ago
(26-Aug-2021)
0/5 (0%)
$36.72 (161.19%)
Buy Since 20-Dec-2016
$34
$31.8 (1445.45%)
$15
8 years 7 months 28 days ago
(11-Jan-2018)
2/2 (100%)
$2.21 (6.95%)
738
What is LPCN (Lipocine) average time for price targets to be met?
Which analyst most recently updated their price target on LPCN (Lipocine)?
Which analyst has the current lower performing score on LPCN (Lipocine) with a proven track record?
Which analyst has the most public recommendations on LPCN (Lipocine)?
Which analyst is the currently most bullish on LPCN (Lipocine)?
Which analyst is the currently most reserved on LPCN (Lipocine)?
